“We have more recently shown that the combined low-dose spironolactone and vitamin E improved NAFLD liver fat score, an index of steatosis, more than vitamin E monotherapy; apart from the liver, spironolactone exhibits anti-fibrotic effects in cardiovascular and renal diseases.”